Abstract
Development of vaccines is a major breakthrough in the fight against the SARS-CoV-2 virus.
Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made.
These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the COVID-19 response and (c) balancing the COVID-19 response with the need to invest in other healthcare that has suffered during the pandemic.
Although these decisions are inherently difficult, principles of good priority setting can be helpful; these principles include: evidence-based and transparent decision-making, participation of stakeholders and a focus on the implementation of decisions.
Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made.
These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the COVID-19 response and (c) balancing the COVID-19 response with the need to invest in other healthcare that has suffered during the pandemic.
Although these decisions are inherently difficult, principles of good priority setting can be helpful; these principles include: evidence-based and transparent decision-making, participation of stakeholders and a focus on the implementation of decisions.
Original language | English |
---|---|
Article number | e004686 |
Number of pages | 4 |
Journal | BMJ Global Health |
Volume | 6 |
Issue number | 1 |
Early online date | 18 Jan 2021 |
DOIs |
|
Publication status | Published - Jan 2021 |
Keywords
- COVID-19 Vaccines/administration & dosage
- COVID-19/epidemiology
- Cost-Benefit Analysis
- Decision Making
- Health Priorities
- Humans
- Pandemics/prevention & control
- SARS-CoV-2